Cecile Philippe

Cecile Philippe is a researcher at the University of Vienna with dual affiliations in the Faculty of Life Sciences (Department of Pharmaceutical Sciences) and the Faculty of Chemistry (Department of Inorganic Chemistry). She holds the academic title Mag. Dr. and has maintained an active research career with 46 publications spanning from 2009 to 2025.

Her research interests focus on Positron Emission Tomography (PET) tracer development, particularly with Carbon-11 and Fluorine-18 isotopes. Her work spans multiple disciplines including tracer pharmacology, neuroimaging, and pharmaceutical sciences. She has made significant contributions to the development of PET tracers for studying neurological conditions like treatment-resistant depression and molecular targets such as Melanin Concentrating Hormone Receptor 1.

Her recent publications demonstrate a strong focus on translational research, with 2025 papers covering both oncology applications of diabetic medications and advanced PET tracer production methods. Her work contributes to UN Sustainable Development Goals related to health and well-being.

Dr. Philippe has been actively involved in collaborative research, particularly with colleagues at the University of Vienna including Wadsak, Hacker, Lanzenberger, and Mitterhauser. Her research has gained significant attention, with publications being picked up by 27 news outlets and shared across multiple social media platforms.